Making autoantibodies safe
- PMID: 18344326
- PMCID: PMC2393817
- DOI: 10.1073/pnas.0801192105
Making autoantibodies safe
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Comment on
-
IgG glycan hydrolysis by a bacterial enzyme as a therapy against autoimmune conditions.Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4265-70. doi: 10.1073/pnas.0711271105. Epub 2008 Mar 10. Proc Natl Acad Sci U S A. 2008. PMID: 18332429 Free PMC article.
References
-
- Dijstelbloem HM, van de Winkel JG, Kallenberg CG. Trends Immunol. 2001;22:510–516. - PubMed
-
- Nimmerjahn F, Ravetch JV. Nat Rev Immunol. 2008;8:34–47. - PubMed
-
- Zlatarova AS, Rouseva M, Roumenina LT, Gadjeva M, Kolev M, Dobrev I, Olova N, Ghai R, Jensenius JC, Reid KB, et al. Biochemistry. 2006;45:9979–9988. - PubMed
-
- Ghai R, Waters P, Roumenina LT, Gadjeva M, Kojouharova MS, Reid KB, Sim RB, Kishore U. Immunobiology. 2007;212:253–266. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
